Comparing a new liquid antacid to chewable Riopan in healthy adults
Part of Digestive system clinical trials.
This trial tests whether a new liquid antacid (Antareit) works as well as the chewable Riopan tablets in healthy people. It involves a small tube placed through your nose to measure stomach acid before and after taking the medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy man or woman between 18 and 45 years old.
- You need to be a non-smoker (or have quit more than 6 months ago).
- Your body mass index (BMI) should be between 18.5 and 30, and you must weigh at least 55 kg if male or 45 kg if female.
- You should have no chronic diseases (like heart, stomach, or immune disorders) and no history of stomach surgery.
- You must be willing to use birth control during the study and for 30 days after.
- You will need to undergo a procedure to measure stomach acid (a thin tube placed through the nose) and provide blood and urine samples.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new topical treatment for people with chronic heartburn and acid regurgitation who don't have erosions (damage) in their esophagus. The treatment is applied directly to the affected area and may help relieve symptoms without taking daily pills.
This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.
This phase 1 trial tests a new medicine called IY-828026 in healthy volunteers to see how safe it is and how the body processes it. It's a first step to find the right dose and check for side effects.
This study tests whether a new version of a medication (AJU-R713) is absorbed into the body the same way as the original (R713R). It's for healthy adults who want to help evaluate the safety and how the body handles the drug.
This trial tests two versions of the same drug to see if they work the same in the body. It's for healthy volunteers who are willing to follow strict guidelines about diet, exercise, and medications.
This trial tests a new heartburn medicine called vonoprazan (10 mg) compared to a placebo (sugar pill) for people with chronic heartburn but no damage to the esophagus. If you have heartburn at least 4 days a week, you may be able to try this once-daily pill for 24 weeks.
Hear when a new Heartburn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.